Literature DB >> 20181551

VEGF hypersecretion as a plausible mechanism for pseudo-meigs' syndrome in advanced colorectal cancer.

Yoshihisa Okuchi1, Satoshi Nagayama, Yukiko Mori, Junichiro Kawamura, Shigemi Matsumoto, Takafumi Nishimura, Akihiko Yoshizawa, Yoshiharu Sakai.   

Abstract

We present a case of pseudo-meigs' syndrome caused by a metastatic ovarian tumor of rectal cancer origin, and examine the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of refractory fluid retention. A 42-year-old woman with advanced rectal cancer underwent a laparoscopic anterior resection of the rectum. During systemic chemotherapy treatment, she complained of severe abdominal distension 16 months following the operation. We failed to improve massive ascites by diuretics and repeated abdominocenteses. Without any definite evidence of carcinomatous peritonitis, we chose to extirpate an enlarged ovarian tumor on the presumptive diagnosis of pseudo-meigs' syndrome. Ascites disappeared promptly after resecting the ovarian tumors and the subject resumed systemic chemotherapy. Preoperative high levels of serum VEGF were normalized promptly after the operation. Levels of VEGF expression in metastatic ovarian tumors were as weak as in the primary tumor upon immunohistochemical staining. In contrast, increased VEGF expression was evident in epithelial cells of oviducts. For patients with massive and refractory ascites, we need to keep in mind the disease entity of pseudo-meigs' syndrome, since surgical intervention possibly improves conditions. Furthermore, the hypersecretion of VEGF from oviducts may play a role in the pathogenesis of clinical manifestations of pseudo-meigs' syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181551     DOI: 10.1093/jjco/hyq014

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  7 in total

1.  Clinical experience of Pseudo-Meigs' Syndrome due to colon cancer.

Authors:  Hiromichi Maeda; Takehrio Okabayashi; Kazuhiro Hanazaki; Michiya Kobayashi
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

2.  Pseudo-Meigs' syndrome secondary to metachronous ovarian metastases from transverse colon cancer.

Authors:  Kennoki Kyo; Atsushi Maema; Motoaki Shirakawa; Toshio Nakamura; Kenji Koda; Hidetaro Yokoyama
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

3.  Etiology of Ascites and Pleural Effusion Associated with Ovarian Tumors: Literature Review and Case Reports of Three Ovarian Tumors Presenting with Massive Ascites, but without Peritoneal Dissemination.

Authors:  Ai Miyoshi; Takashi Miyatake; Takeya Hara; Asuka Tanaka; Naoko Komura; Shinnosuke Komiya; Serika Kanao; Masumi Takeda; Mayuko Mimura; Masaaki Nagamatsu; Takeshi Yokoi
Journal:  Case Rep Obstet Gynecol       Date:  2015-12-17

4.  Pseudo-Meigs' syndrome due to ovarian metastases from colon cancer: a case report and review of the literature.

Authors:  Atsushi Yamamoto; Yoshiaki Miyasaka; Kazushige Furuya; Hideki Watanabe; Masahiro Maruyama; Haruka Nakada; Atsushi Takano; Masao Hada; Hiroshi Nakagomi; Masao Omata; Toshio Oyama
Journal:  Surg Case Rep       Date:  2016-10-12

5.  Long-term survival in pseudo-Meigs' syndrome caused by ovarian metastases from colon cancer.

Authors:  Yosuke Tajima; Hitoshi Kameyama; Saki Yamada; Ryoma Yagi; Masato Nakano; Masayuki Nagahashi; Yoshifumi Shimada; Jun Sakata; Takashi Kobayashi; Hajime Umezu; Toshifumi Wakai
Journal:  World J Surg Oncol       Date:  2016-11-14       Impact factor: 2.754

6.  miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan.

Authors:  Zhang Yue; Zhang Yun-Shan; Xue Feng-Xia
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016 Jul-Sep       Impact factor: 1.636

Review 7.  Pleural Effusion in Meigs' Syndrome-Transudate or Exudate?: Systematic Review of the Literature.

Authors:  Rafal Krenke; Marta Maskey-Warzechowska; Piotr Korczynski; Monika Zielinska-Krawczyk; Joanna Klimiuk; Ryszarda Chazan; Richard W Light
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.